주식/증권
➡️ 중립
3 Reasons to Sell BIIB and 1 Stock to Buy Instead
요약
Biogen has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 14.4% to $218.22 per share while the index has gained 10.5%.